Has Cristina Holtorf received payments from drug or device companies?

Yes. Drug and device makers reported $2,791 in general payments to Cristina Holtorf across 163 transactions between 2019–2025. Most Open Payments records nationally are meals worth under $20; a reported payment is not evidence of wrongdoing.

Does a payment mean Cristina Holtorf did something wrong?

No. Federal law requires drug and device makers to report almost every transfer of value to a physician, including a $14 sandwich at a lunch presentation. Consulting fees, research funding and royalties to device inventors are ordinary, legal parts of medicine. This site reports what was disclosed; it makes no allegation.

Where does this information about Cristina Holtorf come from?

The U.S. Centers for Medicare & Medicaid Services. Payments come from Open Payments, published under the Physician Payments Sunshine Act. Billing and prescribing figures come from the Medicare Physician & Other Practitioners and Part D Prescriber public use files for 2024.

Cristina Holtorf

Nurse Practitioner · Waukee, IANPI 1790440808

Payments from drug & device makers

What this record shows

This record is dominated by food and beverage: $2,491 of the $2,791 with a category attached, or 89.3%. It is spread thinly across 19 manufacturers, the largest accounting for just 17.4% — the pattern of someone who eats at a lot of different presentations. 2025 is the largest year on record at $1,527, more than ten times the $115 reported in 2022. Among nurse practitioner clinicians in IA with any reported payments, this total sits in the top 5% — high for the specialty, which is a reason to read the composition above rather than the number alone.

$2,791in general payments, 2019–2025

Across 163 payments — averaging $17.12 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

AbbVie$486
Johnson & Johnson$384
Novartis$356
Dermavant Sciences, Inc.$305
Sun Pharmaceutical Industries Inc.$244
UCB, Inc.$222
plus $794 from 13 others

What the payments were for

Food & beverage$2,49189%
Education$30011%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

Company	Payments	Total
AbbVie	33	$486
Johnson & Johnson	11	$384
Novartis	17	$356
Dermavant Sciences, Inc.	34	$305
Sun Pharmaceutical Industries Inc.	8	$244
UCB, Inc.	13	$222
Arcutis Biotherapeutics, Inc.	12	$166
Lilly USA, LLC	5	$116
Organon	10	$77
Incyte Corporation	3	$73
Amgen	3	$65
Sanofi	2	$60
Pfizer	2	$48
Regeneron Healthcare Solutions, Inc.	2	$39
E.r. Squibb & Sons, L.L.C.	2	$38
Botanix SB Inc	2	$35
Galderma Laboratories, L.p.	2	$34
Boehringer Ingelheim	1	$23
Ortho Dermatologics, A Division Of Bausch Health US, LLC	1	$20

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

Skyrizi$124

How this compares

$2,791 in reported general payments places this provider in the 95th percentile of 1,346 nurse practitioner providers in Iowa.

See all nurse practitioner providers in Iowa →

Medicare billing

Part B allowed, 2024

$85,675

Medicare patients

376

Services billed

1,874

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

Drug	Claims	Cost to plans & patients
Dupixent SyringeDupilumab	12	$44,904
Ketoconazole	83	$1,273
Clobetasol Propionate	18	$1,167
Metronidazole	24	$821
Tacrolimus	12	$607
Fluocinolone Acetonide	11	$519
Doxycycline Hyclate	19	$506
Clindamycin Phosphate	16	$489
Triamcinolone Acetonide	57	$431
Mometasone Furoate	24	$393
Hydrocortisone	31	$104

Paid to pharmacies, not to this prescriber.

Other nurse practitioner in Waukee

Nicole MorganDes Moines$106K
Julie CoffeyIowa City$31K
Mary JohnsonDavenport$30K
Megan Hart FernandezCedar Rapids$19K
Carla HuberCedar Rapids$18K
Beth ChiaWest Des Moines$15K
Margaret KinneyRed Oak$13K
Abbey ModlinDes Moines$12K
Jonathon HenningsWaterloo$11K
Michaela JohnsonWaterloo$9K

See the full list for Iowa →

Where these figures come from

Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
Identity: NPPES NPI Registry, July 2026.

Is this you, or does something look wrong? →